Appendix 4E and 2017 Financial Report
Filed with ASX · · 61 pages · English
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- Regulatory and Patent approval
- Results of Flavivirus Clinical Trial
- GSS Launches Sexually Transmitted Infection (STI) Kit
- Appendix 4D - Half Yearly Report and Accounts
- 2016 AGM MD and CEO Presentation
Later from Genetic Signatures
- 2017 AGM Presentation
- Appendix 4D and Half Year Financial Statements
- Positive Trial Results Presented at ECCMID
- TGA registration for superbug detection kits
- Major Customer Contract Signed, New Kit and Instrument
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures